Replies to post #13445 on Ariad Pharmaceuticals Inc fka ARIA

[DonShimoda]

I haven't listened yet but I did run through the slides. Perhaps I missed this in a previous presentation, but I noticed that the company is now estimating $1.5 billion peak revenue for front-line CML use, in addition to the $900mm second-line opportunity.